Apolipoprotein E4 Produced in GABAergic Interneurons Causes Learning and Memory Deficits in Mice

Apolipoprotein (apo) E4 is expressed in many types of brain cells, is associated with age-dependent decline of learning and memory in humans, and is the major genetic risk factor for AD. To determine whether the detrimental effects of apoE4 depend on its cellular sources, we generated human apoE knock-in mouse models in which the human APOE gene is conditionally deleted in astrocytes, neurons, or GABAergic interneurons. Here we report that deletion of apoE4 in astrocytes does not protect aged mice from apoE4-induced GABAergic interneuron loss and learning and memory deficits. In contrast, deletion of apoE4 in neurons does protect aged mice from both deficits. Furthermore, deletion of apoE4 in GABAergic interneurons is sufficient to gain similar protection. This study demonstrates a detrimental effect of endogenously produced apoE4 on GABAergic interneurons that leads to learning and memory deficits in mice and provides a novel target for drug development for AD related to apoE4.

[1]  M. Gallagher,et al.  Age‐associated changes in hippocampal‐dependent cognition in Diversity Outbred mice , 2014, Hippocampus.

[2]  Arturo Alvarez-Buylla,et al.  Inhibitory Interneuron Progenitor Transplantation Restores Normal Learning and Memory in ApoE4 Knock-In Mice without or with Aβ Accumulation , 2014, The Journal of Neuroscience.

[3]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[4]  Nicholas M. Vogt,et al.  Hilar interneuron vulnerability distinguishes aged rats with memory impairment , 2013, The Journal of comparative neurology.

[5]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[6]  Yadong Huang,et al.  Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development , 2013, PloS one.

[7]  O. Melemedjian,et al.  Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment , 2013, Molecular pain.

[8]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice , 2012, PloS one.

[9]  R. Mahley,et al.  Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.

[10]  Simon Lovestone,et al.  Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS) , 2012, Neurobiology of Aging.

[11]  Jason J. Corneveaux,et al.  A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline. , 2012, Human molecular genetics.

[12]  Jason J. Corneveaux,et al.  A genome-wide scan for common variants affecting the rate of age-related cognitive decline , 2012, Neurobiology of Aging.

[13]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[14]  A. Gillespie,et al.  Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice , 2012, The Journal of Neuroscience.

[15]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[16]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[17]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.

[18]  L. Mucke,et al.  Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. , 2010, The American journal of pathology.

[19]  Yadong Huang.  Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. , 2010, Trends in molecular medicine.

[20]  P. Hof,et al.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease , 2010, Brain Structure and Function.

[21]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[22]  G. Alexander,et al.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. , 2009, The New England journal of medicine.

[23]  A. Fagan,et al.  Multimodal techniques for diagnosis and prognosis of Alzheimer's disease , 2009, Nature.

[24]  H. Maei,et al.  What is the Most Sensitive Measure of Water Maze Probe Test Performance? , 2009, Front. Integr. Neurosci..

[25]  M. Ekker,et al.  Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons , 2009, Molecular and Cellular Neuroscience.

[26]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[27]  J. F. López-Téllez,et al.  Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease , 2006, Neurobiology of Aging.

[28]  David Walker,et al.  Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.

[29]  H. Federoff,et al.  Synapsin I Cre transgene expression in male mice produces germline recombination in progeny , 2006, Genesis.

[30]  R. Mahley,et al.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Tony Wyss-Coray,et al.  Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.

[32]  L. Mucke,et al.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Uchihara,et al.  Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction , 2003, Stroke.

[34]  H. Onda,et al.  Astrocyte‐specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures , 2002, Annals of neurology.

[35]  D. Selkoe,et al.  The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics , 2002, Science.

[36]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[37]  F. Kuenzi,et al.  Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor , 2002, The Journal of Neuroscience.

[38]  M J West,et al.  Stereological length estimation using spherical probes , 2002, Journal of microscopy.

[39]  D. Holtzman,et al.  Behavioral Phenotyping of GFAP-ApoE3 and -ApoE4 Transgenic Mice: ApoE4 Mice Show Profound Working Memory Impairments in the Absence of Alzheimer's-like Neuropathology , 2001, Experimental Neurology.

[40]  J. Marth,et al.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. , 2001, Genes & development.

[41]  N. Cairns,et al.  Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[42]  A. Delacourte,et al.  Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele , 1998, Neuroscience Letters.

[43]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[45]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[46]  J. D. McGaugh,et al.  Interaction of beta-endorphin and GABAergic drugs in the regulation of memory storage. , 1993, Behavioral and neural biology.

[47]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[49]  Rebecca Burwell,et al.  Severity of spatial learning impairment in aging: Development of a learning index for performance in the Morris water maze. , 1993, Behavioral neuroscience.

[50]  Mark J. West,et al.  Regionally specific loss of neurons in the aging human hippocampus , 1993, Neurobiology of Aging.

[51]  G. Reynolds,et al.  A disorder of cortical GABAergic innervation in Alzheimer's disease , 1987, Neuroscience Letters.

[52]  H. Lauter,et al.  γ-Aminobutyric Acid and Homovanillic Acid Concentration in the CSF of Patients With Senile Dementia of Alzheimer's Type , 1984 .

[53]  M. Franceschi,et al.  Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? , 1982, Archives of Neurology.

[54]  L. Mucke,et al.  Amyloid-beta / Fyn – Induced Synaptic , Network , and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer ’ s Disease , 2015 .

[55]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[56]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[57]  J. Nyengaard,et al.  Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal region , 2001, Hippocampus.

[58]  Paul W. Frankland,et al.  Frontiers in Integrative Neuroscience Integrative Neuroscience , 2022 .